Filing Details
- Accession Number:
- 0000899243-20-004375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 19:03:08
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 19:03:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1192591 | J Charles Homcy | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Chairman Of Pharmaceuticals | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-10 | 20,000 | $36.00 | 1,342,291 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2019.
Billionaire Hedge Funds
